Summit Global Investments Emergent Bio Solutions Inc. Transaction History

Summit Global Investments

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jan 28, 2022	SELL	$56.61 - $80.46 $450,842 - $640,783	-7,964 Closed	0 $0
Q1 2021 Jan 27, 2022	BUY	$86.23 - $125.19 $57,256 - $83,126	664 Added 9.1%	7,964 $740,000
Q4 2020 Feb 11, 2021	BUY	$79.17 - $111.47 $5,225 - $7,357	66 Added 0.91%	7,300 $654,000
Q3 2020 Nov 16, 2020	SELL	$81.91 - $134.94 $635,703 - $1.05 Million	-7,761 Reduced 51.76%	7,234 $747,000
Q2 2020 Aug 11, 2020	SELL	$54.33 - $89.52 $10,866 - $17,904	-200 Reduced 1.32%	14,995 $1.19 Million
Q1 2020 May 14, 2020	SELL	$49.34 - $68.76 $152,954 - $213,156	-3,100 Reduced 16.94%	15,195 $879,000
Q4 2019 Feb 13, 2020	BUY	$51.21 - $59.06 $218,922 - $252,481	4,275 Added 30.49%	18,295 $987,000
Q3 2019 Nov 08, 2019	BUY	$40.6 - $57.2 $569,212 - $801,944	14,020 New	14,020 $733,000
Q4 2018 Feb 08, 2019	SELL	$55.63 - $73.24 $712,064 - $937,471	-12,800 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$48.33 - $55.64 $53,163 - $61,204	1,100 Added 9.4%	12,800 $646,000
Q1 2018 May 03, 2018	BUY	$44.44 - $54.39 $519,948 - $636,363	11,700 New	11,700 $616,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.